Bleomycin Powder, For Solution
Product Images NDC 16714-908
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 16714-908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Container Label (Ble07 0002 02)
The text describes a medicine called Bleomycin in a single-dose vial. It is a cytotoxic agent that must be diluted before use and can be administered through intravenous, intramuscular, subcutaneous or intrapleural use. The usual dosage is to be determined by the indications and precautions mentioned in the package insert. The dry powder must be stored refrigerated and discarded after use. It is sterile, non-pyrogenic and preservative-free. The manufacturer is Northstar Rx LLC, and it is manufactured by Kindos Pharmaceuticals Co., Ltd. No other information is available.*
Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Carton (Ble07 0002 03)
This is a caution about a Cytotoxic Agent, manufactured by Kindos Pharmaceuticals for Injection. The agent, Bleomycin, is indicated for intravenous, intramuscular, subcutaneous or intrapleural use. It must be diluted before use and any unused portion should be discarded. More information regarding dosage and precautions should be obtained from the manufacturer. The container closure is not made with natural rubber latex.*
Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Container Label (Ble07 0002 04)
This is a description of a medication called "Reonly Lyophilized." The package contains a sterile, nonpyrogenic single-dose vial that must be diluted before use. The insert included in the package provides information on indications, dosage, and precautions. The medication is manufactured by Northstar Rx LLC and may be used for intravenous, intramuscular, subcutaneous or intrapleural administration. The dry powder must be refrigerated, and any unused portion should be discarded. The text also provides a caution about the medication being a cytotoxic agent and identifies the manufacturer as Kindos Pharmaceuticals Co., Ltd. The lot number and expiration date are also included.*
Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Carton (Ble07 0002 05)
This is a description of a medication called Bleomycin that comes in a 30 unit per vial dose. Must be diluted before use, for intravenous, intramuscular, subcutaneous, or intrapleural use. The medication is labeled as a cytotoxic agent with a caution label. The insert provides information on indications, dosage, and precautions. The medication is manufactured by Kindos Pharmaceuticals Co., Ltd in China and distributed by Northstar Rx LLC. The container closure does not contain natural rubber latex. The dry powder must be stored refrigerated at 2° to 8°C (36° to 46°F) and any unused portion should be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.